Articles On Cann Group (ASX:CAN)

Listed cannabis stocks worldwide have pulled back from their highs lately, tainted by the vaping crisis in the US. Canopy Growth has seen its share price drift down to just above US$20 from highs of over US$50 in April. Rival Aurora Cannab...

In afternoon trade the S&P/ASX 200 index has followed the lead of U.S. markets and is pushing higher. At the time of writing the benchmark index is up 0.3% to 6,671.5 points. Four shares that have failed to follow the market higher tod...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Monday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.01% to 6...

The Cann Group Ltd (ASX: CAN) share price is down 3.3% to $1.33 this morning after the ‘pot stock’ reported an operating cash loss of $3.55 million on receipts from customers of $1.66 million. It also spent $17.66 million over the quarter...

In the few short years since cannabis companies first floated on stock exchanges around the world, they have developed a reputation for being volatile and high risk. At the start, stocks exploded in value, peaking around the start of 2018....

The Phoslock Environmental Technologies Ltd (ASX: PET) share price is down more than 25% this week after the “environmental technology” business handed in its 4C quarterly cash flow report. For the quarter Phoslock reported a net operating...

Government bodies across the globe are legalising the manufacturing and consumption of medical cannabis products, resulting in vast opportunities for investors. In 2018, Canada became the second largest country in the world to legalise cann...

Cannabis industry in Australia is growing at a fast pace, and government authorities across the country are creating a lot of prospects for investors by legalising medicinal cannabis. Moreover, it is being assumed that the Australia cannabi...

When Ecofibre Ltd (ASX:EOF) released its 4C (quarterly cashflow report) for the three months to 30th September early last week, there was no notable share price reaction. However, we do note straight out of the gates that it was rather earl...

It appears leading Canadian cannabis business Canopy Growth Corp didn’t get the ‘buy low, sell high’ pot stock memo after dumping its 42.08 million shares in Auscann Group Holdings Ltd (ASX: AC8) for just 15 cents per share.  The block tra...

Cannabis Capital Canberra is the capital of Australia, located in the Australian Capital Territory (ACT). The ACT includes the capital of the country and surrounding townships. In historic legislation passed a while ago, the Australian capi...

2018 witnessed several catalysts for the legal cannabis industry, with countries legalising medicinal cannabis, public and private sector getting into constructive discussions about the calibre and cons of the pot industry from a business p...

ASX cannabis shares are struggling to gain momentum in FY19. Interest in the sector has dwindled and sentiment is waning. This could be explained by the short-sighted nature of the market. When there isn’t any groundbreaking news released...

Cannabis company Zelda Therapeutics Ltd (ASX: ZLD) has seen its share price push higher today after it announced a major development. Its shares were up as much as 7.5% to 8.6 cents in morning trade before dropping back a touch. What did Z...

Each Monday, Stockhead recaps which stocks are heavily demanded by investors — or running hot. Stockhead uses the Relative Strength Index (RSI), a technical gauge which measures how trading momentum is affecting the price action. A reading...

Cannabis industry is composed of ancillary products and services, legal cultivators and producers, consumers, researchers, independent industrial standard bodies and regulators. Lately, several companies are getting inclined towards the can...

Although the market is trading within sight of its 52-week high, not all shares have been performing as strongly. Three shares that have just hit 52-week lows or worse are listed below. Here’s why they are down in the dumps: The Cann Group...

The ASX pot stock sector ran hot in 2018 on not much more than media hype, companies spinning stories, and plenty of less-sophisticated investors buying into them. The sector didn’t run higher on share market fundamentals as there were non...

In afternoon trade the S&P/ASX 200 index has given back its early gains and is on course to record another decline. At the time of writing the benchmark index is down 0.3% to 6,687.8 points. Four shares that have fallen more than most...

Usually, when lawmakers take a step further on the road to legalisation, there’s a flurry of speculation around cannabis stocks. However, despite positive news for marijuana enthusiasts from the Australian Capital Territory Legislative Ass...

Elixinol Global (ASX:EXL): It's Not Easy Being Green It’s high time we checked in on Elixinol Global (ASX:EXL) post the release of the company’s 1H19 results late last month and following a very busy last several months which we’ll summaris...

All us Fools are seeking to hit the jackpot on that next investment, but it can be difficult to know where to start. I’ve taken a look at how one big ASX stock bet has the potential to pay off handsomely and make you a millionaire in a mat...

In this day and age, it can be hard to build your portfolio and achieve strong, consistent capital gains in the market. Even the great Warren Buffett himself has seen his market outperformance or “alpha” slowly dwindle over time as we’ve e...

In morning trade the Althea Group Holdings Ltd (ASX: AGH) share price has pushed higher following the release of a market update. At the time of writing the cannabis company’s shares are up 3% to 79.5 cents. What did Althea announce? This...

The Althea Group Holdings Ltd (ASX: AGH) share price has been amongst the best performers on the Australian share market over the last 12 months. Since its 20 cents per share IPO in September of last year, the cannabis company’s shares hav...

With growing focus of governments across the globe on legalising recreational and medicinal cannabis, the cannabis industry is booming at a rapid pace and is expected to offer opportunities for investors. In 2016, Australia became the fourt...

Cannabis: An Overview The cannabis industry is booming at a rapid pace with governments across the globe creating the opportunities for investors by legalising recreational and medicinal cannabis. Legalisation of cannabis by government auth...

In afternoon trade the S&P/ASX 200 index has returned to form and is pushing higher once again. At the time of writing the benchmark index is up 0.5% to 6,473.4 points. Four shares climbing more than most today are listed below. Here’s...

Medicinal pot stock Cann Group (ASX:CAN) is planning to go large at its Mildura-based cannabis manufacturing facility. The company announced revised construction plans this morning which will see an extra production room added, along with d...

27 Aug 2019 - Cann Group (ASX:CAN) plans to increase production of its large-scale state-of-the-art greenhouse facility in Mildura.

The Cann Group Ltd (ASX: CAN) share price has been one of the best performers on the local share market on Tuesday. In morning trade the cannabis company’s shares are up over 12% to $1.92. Why is the Cann share price rocketing higher? Inve...

The increasing use of medical cannabis products has prompted many countries to soften the regulations regarding the manufacturing and consumption of cannabis products. Last year, Canada became the second and the largest country in the world...

‘Pot stocks’ were making headlines in 2018. California, one of the world’s biggest economies and the most populous state in the US, finally enacted legislation to legalise the recreational use of cannabis. It joined a growing list of US st...

Recently, Barbados, a Caribbean country, has introduced the Medicinal Cannabis Industry Act. If passed, it intends to open doors for the medicinal cannabis in the small country. Besides, the bill has proposed to set up a Licensing Authority...

Australia has established its strong position in the contemporary world that is welcoming the good side of cannabis with open arms, amid the recreational legalising debates. The country joined the bandwagon of Alaska, Canada, North Korea an...

Legalisation of Cannabis in Australia Cannabis is widely used for the remedies of Palliative care, Chronic non-cancer pain, Nausea and vomiting, Multiple sclerosis and many more chronic diseases. Before 2016, the production of cannabis was...

The Althea Group Holdings Ltd (ASX: AGH) share price is on course to start the month on a very positive note. In early afternoon trade on Thursday the cannabis company’s shares are up 5.5% to $1.11. Why is the Althea share price charging h...

Data analytics company Nielsen predicts that the American cannabis market will hit $US41 billion ($59.5 billion) by 2025 — a fivefold increase over 2018. While a good chunk of cannabis products are still illegal in the US, Nielsen reckons s...

The progress of the Australian medical cannabis industry since its legalisation indicates that the country is following the footsteps of Canada, attracting established international players. The market experts believe that the Australian ca...

The Cann Group Ltd  (ASX: CAN) share price could trade heavily this morning after the medicinal cannabis company announced its latest quarterly activities to the market. What did the Cann Group announce this morning? In its latest quarterl...

Cannabis can be understood as a nature-oriented medicine from the cannabis plants, used for medical as well as recreational purpose across the globe. Australia enjoys a long history in relation to the manufacturing of pharmaceutical grade m...

Australia’s pharmaceutical industry is innovative and immensely supports economic prosperity of the nation. The constituent companies not only provide treatments to save lives but also contribute to Australian economy by undertaking busines...

The Cann Group got manufacturing licenses for their facilities in Melbourne today, but their main focus will be on the Canadian market. We look at their valuation... The post Cann Group Share Price Up on Licence (ASX:CAN) appeared first on...

The company now holds all cultivation, production and manufacture licences under the Narcotics Drugs Act, along with import and export licences under the Customs Act.

The S&P/ASX 200 index has followed the lead of U.S. markets and dropped lower on Friday. At the time of writing the benchmark index is down 0.2% to 6,802.3 points. Four shares that haven’t let that hold them back are listed below. Here...

One of Australia’s leading cannabis developers, Cann Group (ASX: CAN) has been approved to manufacture cannabis products at its existing northern and southern medicinal cannabis facilities in Melbourne. The licences relate to the manufactur...

Australia’s cannabis industry continues to edge forward under the watchful eye of regulators. For now, it’s the Office of Drug Control’s world — and domestic cannabis companies just live in it. Scroll down for more ASX cannabis news >&gt...

26 Jul 2019 - Medicinal cannabis manufacturer and seller, Cann Group (ASX:CAN), has secured manufacturing licences from the Federal Department of Health’s Office of Drug Control fo…

Impression Healthcare (ASX: IHL) has tweaked its internal structure by appointing Dr Sud Agarwal, a leading figure in the medicinal cannabis industry as its Chief Medical Officer and non-executive director. The newly appointed executive is...

The Althea Group Holdings Ltd (ASX: AGH) share price has returned from its trading halt with a bang this morning. At the time of writing the cannabis company’s shares are up a sizeable 12% to $1.34. Why was Althea in a trading halt? Althea...